Anti-atherogenic effects of resveratrol via liver X receptor α-dependent upregulation of ATP-binding cassette transporters A1 and G1 in macrophages

Journal of Functional Foods

Volumn 4, Issue 4, 2012, Pages 727-735

  Chang, Chun Yu ^a   Lee, Tsung Han ^a,b   Sheu, Wayne H H ^a,c,d,e  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c TAICHUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^d NATIONAL YANG MING UNIVERSITY   (Taiwan)

^e NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Atherosclerosis; ATP binding cassette transporter; Foam cell; LXR ; Resveratrol; Scavenger receptor

Indexed keywords

ARACHIS HYPOGAEA; PISTACIA VERA; RICE STRIPE VIRUS; VITACEAE;

EID: 84866143259     PISSN: 17564646     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jff.2012.04.012     Document Type: Article

References (30)

1. Agarwal B., Baur J.A. Resveratrol and life extension. Annals of the New York Academy of Sciences 2011, 1215:138-143.
2. Araya J., Rodrigo R., Orellana M., Rivera G. Red wine raises plasma HDL and preserves long-chain polyunsaturated fatty acids in rat kidney and erythrocytes. British Journal of Nutrition 2001, 86:189-195.
3. Berrougui H., Grenier G., Loued S., Drouin G., Khalil A. A new insight into resveratrol as an atheroprotective compound: inhibition of lipid peroxidation and enhancement of cholesterol efflux. Atherosclerosis 2009, 207:420-427.
4. Bhat K.P.L., Kosmeder J.W., Pezzuto J.M. Biological effects of resveratrol. Antioxidants and Redox Signaling 2001, 3:1041-1064.
5. Bhavnani B.R., Cecutti A., Gerulath A., Woolever A.C., Berco M. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women. Menopause 2001, 8:408-419.
6. Borra M.T., Smith B.C., Denu J.M. Mechanism of human SIRT1 activation by resveratrol. Journal of Biological Chemistry 2005, 280:17187-17195.
7. Chawla A., Boisvert W.A., Lee C.H., Laffitte B.A., Barak Y., Joseph S.B., Liao D., Nagy L., Edwards P.A., Curtiss L.K., Evans R.M., Tontonoz P. A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 2001, 7:161-171.
8. Cuchel M., Rader D.J. Macrophage reverse cholesterol transport: Key to the regression of atherosclerosis?. Circulation 2006, 113:2548-2555.
9. Cullen J.P., Morrow D., Jin Y., von Sweeney N.O., Sitzmann J.V., Cahill P.A., Redmond E.M. Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. Atherosclerosis 2007, 195:125-133.
10. de Winther M.P., Hofker M.H. Scavenging new insights into atherogenesis. Journal of Clinical Investigation 2000, 105:1039-1041.
11. Ferrero M.E., Bertelli A.E., Fulgenzi A., Pellegatta F., Corsi M.M., Bonfrate M., Ferrara F., De Caterina R., Giovannini L., Bertelli A. Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium. American Journal of Clinical Nutrition 1998, 68:1208-1214.
12. Ji Y., Jian B., Wang N., Moya-Sun M.L., Phillips M.C., Rothblat G.H., Swaney J.B., Tall A.R. Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux. Journal of Biological Chemistry 1997, 272:20982-20985.
13. Kaliora A.C., Dedoussis G.V., Schmidt H. Dietary antioxidants in preventing atherogenesis. Atherosclerosis 2006, 187:1-17.
14. Kleemann R., Zadelaar S., Kooistra T. Cytokines and atherosclerosis: A comprehensive review of studies in mice. Cardiovascular Research 2008, 79:360-376.
15. Kopp P. Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?. European Journal of Endocrinology 1998, 138:619-620.
16. Li A.C., Glass C.K. The macrophage foam cell as a target for therapeutic intervention. Nature Medicine 2002, 8:1235-1242.
17. Linsel-Nitschke P., Tall A.R. HDL as a target in the treatment of atherosclerotic cardiovascular disease. Nature Reviews Drug Discovery 2005, 4:193-205.
18. Manna S.K., Mukhopadhyay A., Aggarwal B.B. Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: potential role of reactive oxygen intermediates and lipid peroxidation. Journal of Immunology 2000, 164:6509-6519.
19. Ou H.C., Chou F.P., Sheen H.M., Lin T.M., Yang C.H., Sheu H.H. Resveratrol, a polyphenolic compound in red wine, protects against oxidized LDL-induced cytotoxicity in endothelial cells. Clinica Chimica Acta 2006, 364:196-204.
20. Poussier B., Cordova A.C., Becquemin J.P., Sumpio B.E. Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis. Journal of Vascular Surgery 2005, 42:1190-1197.
21. Renaud S., de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992, 339:1523-1526.
22. Sevov M., Elfineh L., Cavelier L.B. Resveratrol regulates the expression of LXR-alpha in human macrophages. Biochemical and Biophysical Research Communications 2006, 348:1047-1054.
23. Takahashi K., Takeya M., Sakashita N. Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animals. Medical Electron Microscopy 2002, 35:179-203.
24. Wallerath T., Deckert G., Ternes T., Anderson H., Li H., Witte K., Förstermann U. Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase. Circulation 2002, 106:1652-1658.
25. Wang X., Collins H.L., Ranalletta M., Fuki I.V., Billheimer J.T., Rothblat G.H., Tall A.R., Rader D.J. Macrophage ABCA1 and ABCG1, but not SR-BI, promote macrophage reverse cholesterol transport in vivo. Journal of Clinical Investigation 2007, 117:2216-2224.
26. Wang N., Lan D., Chen W., Matsuura F., Tall A.R. ATP-binding cassette transporters G1 and G4 mediate cellular cholesterol efflux to high-density lipoproteins. Proceedings of the National Academy of Sciences of the United States of America 2004, 101:9774-9779.
27. Wang Z., Zou J., Huang Y., Cao K., Xu Y., Wu J.M. Effect of resveratrol on platelet aggregation in vivo and in vitro. Chinese Medical Journal (English Edition) 2002, 115:378-380.
28. Yokoyama S. Assembly of high density lipoprotein by the ABCA1/apolipoprotein pathway. Current Opinion in Lipidology 2005, 116:269-279.
29. Zhang H., Morgan B., Potter B.J., Ma L., Dellsperger K.C., Ungvari Z., Zhang C. Resveratrol improves left ventricular diastolic relaxation in type 2 diabetes by inhibiting oxidative/nitrative stress: In vivo demonstration with magnetic resonance imaging. American Journal of Physiology - Heart and Circulatory Physiology 2010, 299:H985-H994.
30. Zou J., Huang Y., Chen Q., Wei E., Cao K., Joseph M.W. Effects of resveratrol on oxidative modification of human low density lipoprotein. Chinese Medical Journal (English Edition) 2000, 113:99-102.